English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, May 28, 2020
中国生物制药公布2020年第一季度业绩
中國生物製藥公佈2020年第一季度業績
Sino Biopharmaceutical Announces 2020 First Quarterly Results
Tuesday, May 26, 2020
中国生物制药与康方生物共同开发派安普利新药上市申请获国家药品监督管理局受理
中國生物製藥與康方生物共同開發派安普利新藥上市申請獲國家藥品監督管理局受理
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration
Tuesday, May 19, 2020
中国生物制药与康方生物共同开发派安普利单抗联合安罗替尼一线治疗晚期肝癌的临床试验数据获ASCO年会接受呈列
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting
中國生物製藥與康方生物共同開發派安普利單抗聯合安羅替尼一線治療晚期肝癌的臨床試驗數據獲ASCO年會接受呈列
Monday, March 30, 2020
Sino Biopharm Announces 2019 Annual Results

Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575